Understanding and developing treatments for Central Nervous Disease (CNS) has been hampered by the complexity and the uniqueness of the CNS. This project aims to identify relevant pathways and molecules that can be targeted so that better treatments can evolve.
CNS diseases place a large economic and social burden on patients and their families. This project intends to reduce this problem by identifying new druggable targets.
The project will continue to develop an Intellectual Property estate, achieve external funding and develop a commercial route.
